Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era

[1]  R. McBurney,et al.  Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study , 2020, Multiple Sclerosis and Related Disorders.

[2]  T. Friede,et al.  Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[3]  L. Krupp,et al.  COVID-19 outcomes in MS , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[4]  A. Bar-Or,et al.  Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature , 2020, Nature Reviews Neurology.

[5]  R. Motl,et al.  Health Behaviors, Wellness, and Multiple Sclerosis Amid COVID-19 , 2020, Archives of Physical Medicine and Rehabilitation.

[6]  Abhishek Kumar,et al.  Impact of COVID-19 on U.S. and Canadian neurologists’ therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices , 2020, Journal of Neurology.

[7]  C. Louapre,et al.  Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis. , 2020, JAMA neurology.

[8]  Vijay Kumar Chattu,et al.  Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium , 2020, Frontiers in Neurology.

[9]  M. Sormani,et al.  Disease Modifying Therapies and COVID-19 Severity in Multiple Sclerosis , 2020, SSRN Electronic Journal.

[10]  Jie Pan,et al.  Disease-Modifying Therapies During the COVID-19 Outbreak: A Narrative Review of International and National Recommendations. , 2020, International journal of MS care.

[11]  L. Heinberg,et al.  The COVID-19 Crisis: A Mental Health Perspective and Response Using Telemedicine , 2020, Journal of patient experience.

[12]  Anna María Nápoles,et al.  COVID-19 and Racial/Ethnic Disparities. , 2020, JAMA.

[13]  J. DeLuca,et al.  Treatment and management of cognitive dysfunction in patients with multiple sclerosis , 2020, Nature Reviews Neurology.

[14]  E. Synnott.  Bridging the Gap in Multiple Sclerosis Rehabilitation During Covid-19 , 2020 .